Patterns of recurrence and metastasis in BRCA1/BRCA2 ‐associated breast cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patterns of recurrence and metastasis in
BRCA1/BRCA2
‐associated breast cancers
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-04
DOI
10.1002/cncr.32540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors
- (2018) M Diossy et al. ANNALS OF ONCOLOGY
- Profiles of Brain Metastases: Prioritization of Therapeutic Targets
- (2018) Sherise D. Ferguson et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
- (2018) D Ross Camidge et al. LANCET ONCOLOGY
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer
- (2017) Naama Halpern et al. INTERNATIONAL JOURNAL OF CANCER
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group
- (2017) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations
- (2017) S. Balendran et al. JOURNAL OF NEURO-ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations
- (2016) R. Lewin et al. BREAST CANCER RESEARCH AND TREATMENT
- Twenty-one-gene recurrence score assay inBRCA-associated versus sporadic breast cancers: Differences based on germline mutation status
- (2016) Payal D. Shah et al. CANCER
- Inflammatory breast cancer and development of brain metastases: risk factors and outcomes
- (2015) Laura E. G. Warren et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome
- (2015) Jennifer M. Matro et al. Clinical Breast Cancer
- Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer
- (2015) O. Karginova et al. MOLECULAR CANCER THERAPEUTICS
- Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis
- (2014) Volker Rudat et al. BMC CANCER
- Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers
- (2014) Nadine Tung et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer
- (2014) Stephan Woditschka et al. JNCI-Journal of the National Cancer Institute
- Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients
- (2014) Man-Hsin Hung et al. PLoS One
- Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations
- (2013) S. Bayraktar et al. CLINICAL & EXPERIMENTAL METASTASIS
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
- (2012) Nancy U. Lin et al. CANCER
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- (2012) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers
- (2011) Larissa J. Lee et al. CANCER
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
- (2011) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of and survival following brain metastases among women with inflammatory breast cancer
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia
- (2009) Mario Budroni et al. BMC CANCER
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started